EPi-Sense Guided Coagulation System with Visitrax, MOdel No. CDK-1413 - Product Usage: The EPi-Se...
FDA Device Recall #Z-1887-2019 — Class II — May 29, 2019
Recall Summary
| Recall Number | Z-1887-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | May 29, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | AtriCure, Inc. |
| Location | Mason, OH |
| Product Type | Devices |
| Quantity | 497 |
Product Description
EPi-Sense Guided Coagulation System with Visitrax, MOdel No. CDK-1413 - Product Usage: The EPi-Sense Guided Coagulation System with VisiTrax, consists of a sterile, single-use, disposable coagulation electrode device (1cm, 2cm, and 3cm sizes provided) intended to be used to coagulate cardiac tissue. The flexible, cooled electrode device, with a suction stabilizer feature, transmits radiofrequency (RF) energy from an Electrosurgical Generator (non-sterile, re-useable) connected through an Instrument Cable (sterile). A temporary sensing electrode feature may be used with an off-the-shelf electrogram recording system with the use of an additional instrument cable (non-sterile). An accessory Cannula may be used to facilitate coagulation device access and visibility of the heart. The EPi-Sense Guided Coagulation System with VisiTrax technology is intended for the coagulation of cardiac tissue using Radiofrequency (RF) energy using thoracoscopic, endoscopic, and laparoscopic surgical techniques and may be used for temporary cardiac signal sensing and recording during surgery when connected to a temporary external recording device.
Reason for Recall
The sterile package seal for the Epi-Sense Guided Coagulation System may be compromised, and has a worst-case reasonable harm of infection if used.
Distribution Pattern
Worldwide distribution - US Nationwide distribution, and countries of Germany and Netherlands.
Lot / Code Information
Lots 70638, 71332, 89208, 89938, 90624
Other Recalls from AtriCure, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0927-2024 | Class II | Cryo Module Accessories Domestic CMA-OUS, Pro... | Nov 28, 2023 |
| Z-0928-2024 | Class II | Packaged, Tank Hose Assembly CMA-US, Product Ca... | Nov 28, 2023 |
| Z-0832-2019 | Class II | COBRA FUSION 150 Ablation System (International... | Jan 22, 2019 |
| Z-0831-2019 | Class II | COBRA FUSION 150 Ablation System, Catalog # (RE... | Jan 22, 2019 |
| Z-0830-2019 | Class II | COBRA FUSION 150 Ablation System, Catalog # (RE... | Jan 22, 2019 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.